PRETI, PAOLA STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 9.621
AS - Asia 7.538
EU - Europa 6.237
SA - Sud America 732
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 24.336
Nazione #
US - Stati Uniti d'America 9.419
CN - Cina 4.010
SG - Singapore 1.753
IE - Irlanda 1.149
UA - Ucraina 1.080
DE - Germania 933
FI - Finlandia 830
HK - Hong Kong 617
VN - Vietnam 538
BR - Brasile 518
IT - Italia 514
RU - Federazione Russa 507
SE - Svezia 406
FR - Francia 340
GB - Regno Unito 237
IN - India 119
CA - Canada 106
BD - Bangladesh 84
AR - Argentina 78
ZA - Sudafrica 78
NL - Olanda 68
IQ - Iraq 67
MX - Messico 53
PK - Pakistan 41
JP - Giappone 38
TR - Turchia 33
EC - Ecuador 29
SA - Arabia Saudita 29
CL - Cile 26
ES - Italia 26
MA - Marocco 26
VE - Venezuela 25
CO - Colombia 24
PL - Polonia 24
ID - Indonesia 23
MY - Malesia 22
PH - Filippine 22
TH - Thailandia 22
GR - Grecia 21
KE - Kenya 21
UZ - Uzbekistan 19
RO - Romania 17
BE - Belgio 16
EG - Egitto 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 12
JO - Giordania 12
AZ - Azerbaigian 11
CH - Svizzera 11
CR - Costa Rica 9
KZ - Kazakistan 9
PE - Perù 9
EU - Europa 8
IL - Israele 8
NP - Nepal 8
PY - Paraguay 8
UY - Uruguay 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
MU - Mauritius 7
PA - Panama 7
AT - Austria 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
LT - Lituania 6
MK - Macedonia 6
AU - Australia 5
IR - Iran 5
NI - Nicaragua 5
SI - Slovenia 5
SN - Senegal 5
AL - Albania 4
BG - Bulgaria 4
KR - Corea 4
KW - Kuwait 4
OM - Oman 4
QA - Qatar 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
CI - Costa d'Avorio 3
HN - Honduras 3
HU - Ungheria 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
DM - Dominica 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
Totale 24.318
Città #
Jacksonville 1.347
Chandler 1.310
Dublin 1.148
San Jose 1.120
Nanjing 985
Singapore 861
Ashburn 690
Hong Kong 604
Dallas 582
Boardman 475
Nanchang 419
Beijing 408
Princeton 393
Munich 339
Hebei 309
Shenyang 288
Lawrence 287
Changsha 274
Wilmington 256
Lauterbourg 252
Helsinki 248
Jiaxing 207
Hangzhou 184
Ho Chi Minh City 184
Los Angeles 177
Tianjin 176
Hanoi 138
Milan 138
Medford 119
Redondo Beach 118
Council Bluffs 114
New York 110
Moscow 91
Buffalo 90
Ann Arbor 89
Shanghai 65
Johannesburg 62
Norwalk 57
Woodbridge 51
Toronto 49
Cambridge 48
Santa Clara 48
São Paulo 48
Seattle 45
Kunming 40
Tokyo 36
Da Nang 35
Turku 34
Verona 33
Baghdad 30
Brooklyn 29
Guangzhou 28
Des Moines 26
Pavia 26
Montreal 25
Atlanta 24
Orem 24
Frankfurt am Main 23
Jinan 23
Stockholm 23
Fairfield 22
Warsaw 22
Chennai 21
Ningbo 21
Boston 20
Chicago 19
Haiphong 19
Zhengzhou 19
Tashkent 17
Brussels 16
Denver 16
Mexico City 16
Nairobi 16
Rio de Janeiro 16
San Francisco 16
Phoenix 15
Dhaka 14
Houston 14
Jeddah 14
London 14
Amsterdam 13
Lanzhou 13
Rome 13
Santiago 13
Nuremberg 12
Quito 12
Vancouver 12
Baku 11
Changchun 11
Guayaquil 11
Magenta 11
Pune 11
Borås 10
Casablanca 10
Istanbul 10
Manchester 10
Mumbai 10
Naples 10
Thái Nguyên 10
Timisoara 10
Totale 16.032
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 339
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 292
Anemia in patients with Covid-19: pathogenesis and clinical significance 288
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 251
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 190
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 173
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 160
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria. 147
Abscisic Acid Treatment in Patients with Prediabetes. 142
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 139
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 133
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 131
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients 130
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 126
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 125
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. 122
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. 121
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 120
Effect of valsartan amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients 118
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 117
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 117
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination 116
Adding Losartan to Lisinopril Therapy in Patients with Hypertension: Assessment by 24-hour Ambulatory Blood Pressure Monitoring. 114
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 111
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension 110
Beta-blockers effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia 110
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 109
Effects of Amlodipine, Nifedipine GITS anf Indomethacin on Angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked croossover study 107
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. 107
Influence of valsartan and enelapril on cognitive function in elderly hypertensive patients. 107
Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients:a double-blind, randomized, parallel-group study . 107
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 107
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 106
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 105
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients. 105
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 105
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation 102
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update 102
A rare case of a patient with hemophilia presenting elbow-ankylosing heterotopic ossification: surgery and functional outcomes. 101
Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients 100
Comparative Efficacy of Losartan and Valsartan in Mild-to-Moderate Hypertension : results of 24-Hour Ambulatory Blood Pressure Monitoring. 100
. Prevalence of primary aldosteronism among unselected hypertensive patients 99
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. 99
. Prevalence of primary aldosteronism among hypertensive patients. 99
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 98
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 98
Effect of Valsartan and Atenolol on sexual behavior in hypertensive postmenopausal women. 97
Effect of amlodipine vs candesartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients 97
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 96
. Effects of telmisartan hydrochlorothiazide combination versus nifedipine gits on blood pressure and sympathetic activity in hypertension. 96
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 96
Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring 95
. Effect of benazepril amlodipine combination on fibrinolysis in hypertensivw diabetic patients. 94
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men 93
Effects of valsartan and olmesartan Addition to amlodipine on ankle oedema in hypertensive patients 93
Different effects of aliskiren/hydrochlorotiazide and atenol/hydrochlorotiazide combinations on central pressure in elderly hypertensive patients 93
Effetto della combinazione valsartan-amlodipina sulla funzione cognitiva in pazienti ipertesi anziani 93
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men 92
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 92
Effect of benazepril amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients. 92
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. 92
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients 92
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 91
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 91
Effect of valsartan on insulin sensitivity and leptin in hypertensive obese patients 91
Valsartan amlodipine combination and prevention of atrial fibrillation recurrence in hypertensive diabetic patients 91
Early development of metabolic syndrome in patients subjected to lung transplantation 91
Valsartan amlodipine combination and prevention of atrial fibrillation recurrence in hypertensive diabetic patients 90
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes 90
Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. 90
Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia. 90
Effect of aliskiren addition to losartan on fibrinolysis in diabetic hypertensive patients: a three-way crossover study. 89
Prevalence of primary aldosteronism among unselected hypertensive patients 89
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine 88
Sexual activity and plasma testosterone levels in hypertensive males. 88
Effect of telmisartan and ramipril on arial fibrillation episodes recurrence and severity in hypertensive patients with metabolic syndrome and lone paroxysmal atrial fibrillation 88
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension 88
Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome 88
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. 88
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial 87
Effects of pravastatin given every other day in dyslipidemic hypertensive patients treated with different antihypertensive drugs 87
Effects of Amlodipine, Nifedipine GITS, and Indomethacin on Angiotensin-Converting Enzyme Inhibitor-Induced Cough : A Randomized, Placebo-Controlled, Double-Masked, Crossover Study. 86
Effect of valsartan on adiponectine, leptin and resistine in hypertensive obese patients 86
Comparative evaluation of telmisartan and eprosartan effect on insulin sensitivity in hypertensive patients with metabolic syndrome 86
Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients 86
Effect of valsartan compared to losartan on insulin-resisstance parameters in overweight hypertensive patients 86
Lone paroxysmal atrial fibrillation and inflammatory markers in essential hypertension 85
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 85
Effetti dell'associazione valsartan-amlodipina sui marcatori dell'infiammazione, sullo stress ossidativo e sulla dimetilarginina asimmetrica nei pazienti ipertesi con diabete di tipo 2 85
DIFFERENCE IN INCIDENCE OF COUGH INDUCED BY IMlDAPRlL AND RAMIPRlL: ROLE OF PROSTAGLANDIN SYNTHESIS INHIBITION 85
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 85
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria 85
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. 84
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine. 84
Effect of manidipine and nifedipine on plasma active renin and aldosterone in essential hypertensive patients 84
Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria 84
RENIN-ANGIOTENSIN SYSTEM AND ATRIAL FIBRILLATION 84
DIFFERENT EFFECTS OF ALISKIREN/IHYDROCHLOROTIAZIDE ANDATENOLOL/lHYDROCHLOROTIAZIDE COMBINATIONS ON CENTRAL PRESSURE IN ELDERLY HYPERTENSIVE PATIENTS 84
Olmesartan medoxomil: recent clinical and experimental acquisitions 83
Totale 10.980
Categoria #
all - tutte 99.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 0 0 0 0 61
2021/20221.047 21 7 42 4 8 15 13 75 62 22 191 587
2022/20233.681 413 212 14 315 458 433 0 230 1.400 43 100 63
2023/20241.100 112 194 29 62 200 250 38 111 12 38 23 31
2024/20253.459 38 323 84 140 60 165 296 384 756 50 353 810
2025/20267.484 581 528 786 681 815 368 1.755 290 667 545 324 144
Totale 24.446